Sequential therapy versus the best quadriple drug therapy for helicobacter pylori eradicatio
Not Applicable
- Conditions
- Peptic Ulcer Disease (H. Pylori eradication).Duodenal ulcer
- Registration Number
- IRCT138807022499N1
- Lead Sponsor
- Vice Chancellor For Research, Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 296
Inclusion Criteria
age more than 18 years
Exclusion criteria: Previous history of receiving any H.p eradication regimen, Taking H2 blocker, proton pump inhibitor, Bismuth or Antibiotics during the 2 weeks prior to the study, Taking anticoagulants, ketoconazole or corticosteroids, History of gastric or esophageal surgery, Severe cardiovascular, pulmonary or endocrine disease, Renal failure, Hepatic diseases, Malignancies, Alcoholism, G6PD deficiency, Pregnancy or breast feeding
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Helicobacter pylori eradication. Timepoint: 2 months after the completion of treatment course. Method of measurement: urease breating test.
- Secondary Outcome Measures
Name Time Method Side effects of drugs. Timepoint: daily recording during and after the treatmen course. Method of measurement: classifying as mild, moderate or severe side effects.